The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 9 of 33
Back to Result List

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Emma Guttman-Yassky, Patrick M. Brunner, Avidan Neumann, Saakshi Khattri, Ana B. Pavel, Kunal Malik, Giselle K. Singer, Danielle Baum, Patricia Gilleaudeau, Mary Sullivan-Whalen, Sharon Rose, Shelbi Jim On, Xuan Li, Judilyn Fuentes-Duculan, Yeriel Estrada, Sandra Garcet, Claudia Traidl-HoffmannORCiDGND, James G. Krueger, Mark G. Lebwohl
URN:urn:nbn:de:bvb:384-opus4-768357
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/76835
ISSN:0190-9622OPAC
Parent Title (English):Journal of the American Academy of Dermatology
Publisher:Elsevier BV
Type:Article
Language:English
Year of first Publication:2018
Publishing Institution:Universität Augsburg
Release Date:2020/06/12
Tag:Dermatology
Volume:78
Issue:5
First Page:872
Last Page:881.e6
DOI:https://doi.org/10.1016/j.jaad.2018.01.016
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Umweltmedizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY-NC-ND 4.0: Creative Commons: Namensnennung - Nicht kommerziell - Keine Bearbeitung (mit Print on Demand)

OPUS4 Logo